Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: EPIGENDX INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-08-24 to 2022-09-30
Current total value of award: $14992.6
Description: NIDDK - TARGETED NEXTGEN BISULIFTE SEQEUNCING